<html xmlns:mims="http://www.mims.com"><head><link type="text/css" href="css/redmond/jquery-ui-1.8.6.custom.css" rel="stylesheet" /><link type="text/css" href="css/mims.css" rel="stylesheet" /><script type="text/javascript" src="scripts/jquery-1.4.4.min.js"></script><script type="text/javascript" src="scripts/jquery-ui-1.8.6.custom.min.js"></script><script type="text/javascript" src="scripts/monograph.js"></script></head><body><div id="tabs"><ul><li><a href="#tab-generic">Generic</a></li></ul><div id="tab-generic"><h4 class="subheading"></h4><table class="ui-widget monograph"><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Dosage</span></td><td class="ui-widget-content"><I>Oral</I><BR><B> Oedema</B><BR><B><I>Adult: </I></B>Initially, 100 mg daily, may adjust dose according to response up to 400 mg daily. <BR><B><I>Child: </I></B>Neonates: 1-2 mg/kg daily; 1 mth-12 yr: 1-3 mg/kg daily; 12-18 yr: 50-100 mg daily. To be given in 1-2 divided doses.

<BR><B><I>Elderly: </I></B>Initially, 25-50 mg/day in 1-2 divided doses, may increase by 25-50 mg every 5 days when necessary. <table border=''1''><tr><td><B>CrCl (ml/min)</B></td><td><B>Dosage Recommendation</B></td></tr><tr><td>10-50</td><td>Recommended dosing interval: Every 12-24 hr. </td></tr><tr><td>10</td><td>Avoid use.</td></tr></table><BR><I>Oral</I><BR><B> Hepatic cirrhosis with ascites and oedema</B><BR><B><I>Adult: </I></B>Depending on urinary sodium/potassium ratio: If &amp;gt;1: Initially, 100 mg daily and if 1: Initially, 200-400 mg daily.<BR><B><I>Child: </I></B>Neonate: 1-2 mg/kg daily (Max: 7 mg/kg daily in resistant ascites); 1 mth-12 yr: 1-3 mg/kg daily (Max: 9 mg/kg daily in resistant ascites); 12-18 yr: 50-100 mg daily (Max: 400 mg daily in resistant ascites). To be given in 2 divided doses.

<BR><B><I>Elderly: </I></B>Dosing adjustment may be required. <table border=''1''><tr><td><B>CrCl (ml/min)</B></td><td><B>Dosage Recommendation</B></td></tr><tr><td>10-50</td><td>Recommended dosing interval: Every 12-24 hr. </td></tr><tr><td>10</td><td>Avoid use. </td></tr></table><BR><I>Oral</I><BR><B>Diagnosis of primary hyperaldosteronism</B><BR><B><I>Adult: </I></B>400 mg daily for 3-4 wk. Correction of serum potassium levels and hypertension gives the presumptive evidence for the diagnosis of primary aldosteronism. <BR><B><I>Elderly: </I></B>Dosing adjustment may be required. <table border=''1''><tr><td><B>CrCl (ml/min)</B></td><td><B>Dosage Recommendation</B></td></tr><tr><td>10-50</td><td>Recommended dosing interval: Every 12-24 hr. </td></tr><tr><td>10</td><td>Avoid use. </td></tr></table><BR><I>Oral</I><BR><B>Preoperative management of hyperaldosteronism</B><BR><B><I>Adult: </I></B>100-400 mg daily. Long term maintenance in the absence of surgery: May initiate at 400 mg daily and maintain at 100-300 mg daily; lowest effective dose should be used. <BR><B><I>Elderly: </I></B>Dosing adjustment may be required. <table border=''1''><tr><td><B>CrCl (ml/min)</B></td><td><B>Dosage Recommendation</B></td></tr><tr><td>10-50</td><td>Recommended dosing interval: Every 12-24 hr. </td></tr><tr><td>10</td><td>Avoid use. </td></tr></table><BR><I>Oral</I><BR><B>Hypertension</B><BR><B><I>Adult: </I></B>As monotherapy: Usual dose range: 25-50 mg daily, may increase up to 100 mg daily if needed. <BR><B><I>Elderly: </I></B>Initially, 25-50 mg/day in 1-2 divided doses, may increase by 25-50 mg every 5 days when necessary. <table border=''1''><tr><td><B>CrCl (ml/min)</B></td><td><B>Dosage Recommendation</B></td></tr><tr><td>10-50</td><td>Recommended dosing interval: Every 12-24 hr. </td></tr><tr><td>10</td><td>Avoid use. </td></tr></table><BR><I>Oral</I><BR><B>Severe congestive heart failure</B><BR><B><I>Adult: </I></B>For patients receiving an ACE inhibitor and a loop diuretic with or without a cardiac glycoside: Initially, 12.5-25 mg daily. May increase to 50 mg daily after 8 wk of treatment depending on response. <BR><B><I>Child: </I></B>Neonates: 1-2 mg/kg daily; 1 mth-12 yr: 1-3 mg/kg daily; 12-18 yr: 50-100 mg daily. To be given in 1-2 divided doses. <BR><B><I>Elderly: </I></B>Dosing adjustment may be required. <table border=''1''><tr><td><B>CrCl (ml/min)</B></td><td><B>Dosage Recommendation</B></td></tr><tr><td>10-50</td><td>Recommended dosing interval: Every 12-24 hr. </td></tr><tr><td>10</td><td>Avoid use. </td></tr></table><BR><I>Oral</I><BR><B>Diuretic-induced hypokalaemia</B><BR><B><I>Adult: </I></B>25-100 mg daily. <BR><B><I>Child: </I></B>Neonates: 1-2 mg/kg daily; 1 mth-12 yr: 1-3 mg/kg daily; 12-18 yr: 50-100 mg daily. To be given in 1-2 divided doses.<BR><B><I>Elderly: </I></B>Dosing adjustment may be required. <table border=''1''><tr><td><B>CrCl (ml/min)</B></td><td><B>Dosage Recommendation</B></td></tr><tr><td>10-50</td><td>Recommended dosing interval: Every 12-24 hr. </td></tr><tr><td>10</td><td>Avoid use. </td></tr></table><BR><I>Oral</I><BR><B> Hirsutism</B><BR><B><I>Adult: </I></B>50-200 mg daily. <BR><B><I>Elderly: </I></B>Dosing adjustment may be required. <table border=''1''><tr><td><B>CrCl (ml/min)</B></td><td><B>Dosage Recommendation</B></td></tr><tr><td>10-50</td><td>Recommended dosing interval: Every 12-24 hr. </td></tr><tr><td>10</td><td>Avoid use. </td></tr></table></td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Administration</span></td><td class="ui-widget-content">Should be taken with food.<br></td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Contraindications</span></td><td class="ui-widget-content">Anuria, hyperkalaemia, acute or progressive renal insufficiency. Addison''s disease.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Special precautions</span></td><td class="ui-widget-content">Patients at risk of developing hyperkalaemia and acidosis; monitor serum electrolytes; renal and hepatic impairment; DM; elderly; pregnancy.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Adverse reactions</span></td><td class="ui-widget-content">Fluid or electrolyte imbalance, gynaecomastia, GI upset, drowsiness, headache, hyponatraemia; tachycardia, hypotension, oliguria, hyperkalaemia; confusion, weakness, paraesthesia, hirsutism, mental disturbances, menstrual irregularities, loss of libido and impotence.<BR/> <B>Potentially Life-Threatening Adverse Drug Reaction: </B>Fatal hyperkalaemia in combination with ACE inhibitors and previous renal impairment; agranulocytosis.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Drug interactions</span></td><td class="ui-widget-content">Sodium excretion effect may be inhibited by aspirin. May reduce ulcer-healing properties of carbenoxolone. Increased risk of nephrotoxicity when used with NSAIDs or ciclosporin. Hyperkalaemia may occur if given with potassium supplements, ACE  inhibitors, angiotensin II antagonists, NSAIDs, ciclosporin or trilostane. May increase risk of orthostatic hypotension when used with barbiturates, narcotics or alcohol. May reduce vascular responsiveness to pressor amines. May increase half-life of digoxin.<BR/> <B>Potentially Hazardous Interaction: </B>Increased risk of lithium toxicity when used concurrently.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Mechanism of action</span></td><td class="ui-widget-content">Spironolactone acts on the distal renal tubules as a competitive antagonist of aldosterone. It increases the excretion of sodium chloride and water while conserving potassium and hydrogen ions.<BR><B>Absorption: </B>Well absorbed from the GI tract after oral admin with a bioavailability of 90%.<BR><B>Distribution: </B>About 90% bound to plasma proteins.<BR><B>Metabolism: </B>Extensively metabolised.<BR><B>Excretion: </B>Mainly excreted in the urine, some in the faeces, as metabolites.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Lab Interference</span></td><td class="ui-widget-content">Interferes with fluorometric measurements of plasma cortisol, immunoassays for serum digoxin, and estimations of 17-ketosteroids and 17-ketogenic steroids.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Food Interaction</span></td><td class="ui-widget-content">Improved absorption if taken after food.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">MIMS Class</span></td><td class="ui-widget-content">Diuretics</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">ATC Classification</span></td><td class="ui-widget-content">C03DA01 - spironolactone; Belongs to the class of potassium-sparing agents, aldosterone antagonists. Used as diuretics.<BR></td></tr></table></div></div></body></html>